Currently Viewing:
Currently Reading
What We're Reading: CMS May Require Medicare Hospitals Follow New Antibiotic Controls
June 14, 2016 – AJMC Staff
Survey Finds Family Physicians Divided on Recommending LDCT Screening
June 13, 2016 – Surabhi Dangi-Garimella, PhD
Vitamin D Reduces Hyperglycemia Risk Associated With Atypical Antipsychotics
June 12, 2016 – Jessica Men
Flu Shot Associated With Extra Benefits in Patients With Heart Failure
June 11, 2016 – Jackie Syrop
This Week in Managed Care: June 11, 2016
June 11, 2016
Duchenne Muscular Dystrophy Treatments in a State of Flux
June 11, 2016 – Jackie Syrop
What We're Reading: Carolinas HealthCare System Faces Antitrust Allegations
June 10, 2016 – AJMC Staff
Systemic Lupus Erythematosus a Risk Factor for Cervical Cancer
June 10, 2016 – AJMC Staff
NICE Not Alone in Pushback on Cancer Drug Prices
June 10, 2016 – Surabhi Dangi-Garimella, PhD

What We're Reading: CMS May Require Medicare Hospitals Follow New Antibiotic Controls

AJMC Staff
What we're reading, June 14, 2016: CMS has proposed requiring Medicare hospitals follow new antibiotic controls; New York poised to expand access to breast cancer screening; and clinical trials are seeing more success.
CMS has proposed that Medicare hospitals closely manage the use of antibiotics or be ejected from the program. According to The Wall Street Journal, CMS would require that hospitals adopt new antibiotic controls in an attempt to reduce overuse. Federal health officials are concerned about the growing threat of antibiotic resistant bacteria. Under the proposal, hospitals would have someone in charge of antibiotic oversight.

New York is looking to increase access to breast cancer screening under a new deal by lawmakers. Hospitals would be required to expand hours when mammograms are offered and insurers would have to eliminate deductibles and copays for some diagnostic tests, including screening, reported the AP. The measure is expected to pass with the support of Governor Andrew Cuomo, the Democratic assembly speaker, and the Republican senate leader.

Clinical trials are reporting greater success rates. STAT reported that more than 11% of clinical trials succeeded between 2012 and 2014, which reversed the downward trend of the last 2 decades. The declines in clinical trial success rates was attributed to many drug makers cutting back on R&D. The success rate had bottomed out at 7.5% between 2008 and 2011, which was far below the 16.4% success rate seen between 1996 and 1999.

Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up